These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15454101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of hyperparathyroidism on blood lead concentrations in man.
    Osterloh JD, Clark OH.
    Environ Res; 1993 Jul; 62(1):1-6. PubMed ID: 8325255
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A, Dicembrino F, Chiodini I, Minisola S, Fusilli S, Di Giorgio A, Garrubba M, D'Aloiso L, Frusciante V, Torlontano M, Modoni S, Trischitta V, Trischitta V, Carnevale V.
    Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
    [Abstract] [Full Text] [Related]

  • 6. Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism.
    Takami H, Ikeda Y, Hayashi K, Hayashi M, Konishi K, Saruta T, Carpi A.
    Biomed Pharmacother; 1999 Aug; 53(7):329-33. PubMed ID: 10472434
    [Abstract] [Full Text] [Related]

  • 7. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
    Yamashita H, Noguchi S, Moriyama T, Takamatsu Y, Sadanaga K, Uchino S, Watanabe S, Ogawa T.
    Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.
    Lundgren E, Hagström EG, Lundin J, Winnerbäck K, Roos J, Ljunghall S, Rastad J.
    World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863
    [Abstract] [Full Text] [Related]

  • 12. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
    Steiniche T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE, Melsen F.
    Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S.
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [Abstract] [Full Text] [Related]

  • 18. Prediction of changes in bone density after operation for primary hyperparathyroidism.
    Bergenfelz A, Lindergård B, Ahrén B.
    Ann Chir Gynaecol; 1993 Nov; 82(4):245-9. PubMed ID: 8122872
    [Abstract] [Full Text] [Related]

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 20. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.